Literature DB >> 12193731

Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration.

Birgit I Schenk1, Frank Petersen, Hans-Dieter Flad, Ernst Brandt.   

Abstract

In this study, we have examined the major platelet-derived CXC chemokines connective tissue-activating peptide III (CTAP-III), its truncation product neutrophil-activating peptide 2 (CXC chemokine ligand 7 (CXCL7)), as well as the structurally related platelet factor 4 (CXCL4) for their impact on neutrophil adhesion to and transmigration through unstimulated vascular endothelium. Using monolayers of cultured HUVEC, we found all three chemokines to promote neutrophil adhesion, while only CXCL7 induced transmigration. Induction of cell adhesion following exposure to CTAP-III, a molecule to date described to lack neutrophil-stimulating capacity, depended on proteolytical conversion of the inactive chemokine into CXCL7 by neutrophils. This was evident from experiments in which inhibition of the CTAP-III-processing protease and simultaneous blockade of the CXCL7 high affinity receptor CXCR-2 led to complete abrogation of CTAP-III-mediated neutrophil adhesion. CXCL4 at substimulatory dosages modulated CTAP-III- as well as CXCL7-induced adhesion. Although cell adhesion following exposure to CTAP-III was drastically reduced, CXCL7-mediated adhesion underwent significant enhancement. Transendothelial migration of neutrophils in response to CXCL7 or IL-8 (CXCL8) was subject to modulation by CTAP-III, but not CXCL4, as seen by drastic desensitization of the migratory response of neutrophils pre-exposed to CTAP-III, which was paralleled by selective down-modulation of CXCR-2. Altogether our results demonstrate that there exist multiple interactions between platelet-derived chemokines in the regulation of neutrophil adhesion and transendothelial migration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193731     DOI: 10.4049/jimmunol.169.5.2602

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

Review 1.  Platelets as initiators and mediators of inflammation at the vessel wall.

Authors:  Guanfang Shi; Craig N Morrell
Journal:  Thromb Res       Date:  2010-11-20       Impact factor: 3.944

2.  Going from genes to proteins in myelodysplastic syndromes.

Authors:  Arnold Ganser; Michael A Morgan; Eva M Weissinger
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-19       Impact factor: 11.205

Review 3.  Proteomics: applications in transfusion medicine.

Authors:  Giancarlo Maria Liumbruno
Journal:  Blood Transfus       Date:  2008-04       Impact factor: 3.443

Review 4.  Platelet-derived chemokines: pathophysiology and therapeutic aspects.

Authors:  Hans-Dieter Flad; Ernst Brandt
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

Review 5.  Leukocyte-rich PRP versus leukocyte-poor PRP - The role of monocyte/macrophage function in the healing cascade.

Authors:  José Fábio Lana; Stephany Cares Huber; Joseph Purita; Claudia H Tambeli; Gabriel Silva Santos; Christian Paulus; Joyce M Annichino-Bizzacchi
Journal:  J Clin Orthop Trauma       Date:  2019-05-13

6.  Elevated levels of CXC chemokine connective tissue activating peptide (CTAP)-III in lung cancer patients.

Authors:  Gina Lee; Brian K Gardner; David A Elashoff; Colleen M Purcell; Harpavan S Sandha; Jenny T Mao; Kostyantyn Krysan; Jay M Lee; Steven M Dubinett
Journal:  Am J Transl Res       Date:  2011-04-02       Impact factor: 4.060

Review 7.  Cancer and inflammation.

Authors:  Lance L Munn
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-12-12

Review 8.  Platelet alpha-granules: basic biology and clinical correlates.

Authors:  Price Blair; Robert Flaumenhaft
Journal:  Blood Rev       Date:  2009-05-17       Impact factor: 8.250

9.  Platelet factor 4 is highly upregulated in dendritic cells after severe trauma.

Authors:  Marcus Maier; Emanuel V Geiger; Dirk Henrich; Carolyn Bendt; Sebastian Wutzler; Mark Lehnert; Ingo Marzi
Journal:  Mol Med       Date:  2009-08-27       Impact factor: 6.354

10.  PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis.

Authors:  Grant D Barish; Annette R Atkins; Michael Downes; Peter Olson; Ling-Wa Chong; Mike Nelson; Yuhua Zou; Hoosang Hwang; Heonjoong Kang; Linda Curtiss; Ronald M Evans; Chih-Hao Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.